Your browser doesn't support javascript.
loading
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry.
Gisondi, P; Bianchi, L; Conti, A; Dapavo, P; Malagoli, P; Piaserico, S; Savoia, F; Prignano, F; Girolomoni, G.
Afiliação
  • Gisondi P; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
  • Bianchi L; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
  • Conti A; Department of Head and Neck Surgery, Section of Dermatology, Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy.
  • Dapavo P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Malagoli P; Section of Dermatology, I.R.C.C.S. Policlinico San Donato, Milan, Italy.
  • Piaserico S; Department of Medicine, Section of Dermatology, University of Padua, Padua, Italy.
  • Savoia F; Dermatology, Ospedale 'Umberto I' di Lugo, Ravenna, Italy.
  • Prignano F; Department of Surgery and Translational Medicine, Section of Dermatology, University of Florence, Florence, Italy.
  • Girolomoni G; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Br J Dermatol ; 177(6): e325-e326, 2017 12.
Article em En | MEDLINE | ID: mdl-28498543

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article